^
No biomarker
Uveal Melanoma
TC
Sensitive
:
A2
No biomarker
Uveal Melanoma
pembrolizumab
Sensitive
:
A2
No biomarker
Uveal Melanoma
nivolumab
Sensitive
:
A2
No biomarker
Uveal Melanoma
ipilimumab
Sensitive
:
A2
No biomarker
Uveal Melanoma
dacarbazine
Sensitive
:
A2
No biomarker
Uveal Melanoma
temozolomide
Sensitive
:
A2
No biomarker
Uveal Melanoma
trametinib
Sensitive
:
A2
No biomarker
Uveal Melanoma
paclitaxel
Sensitive
:
A2
No biomarker
Uveal Melanoma
albumin-bound paclitaxel
Sensitive
:
A2
No biomarker
Uveal Melanoma
nivolumab + ipilimumab
Sensitive
:
A2
No biomarker
Uveal Melanoma
CaT
Sensitive
:
A2
HLA-A positive
Uveal Melanoma
IMCgp100
Sensitive
:
B
BRAF V600
Ocular Melanoma
vemurafenib
Sensitive
:
C1
BRAF V600
Ocular Melanoma
trametinib + dabrafenib
Sensitive
:
C1
BRAF V600E
Ocular Melanoma
trametinib + dabrafenib
Sensitive
:
C1
GNA11 mutation
Uveal Melanoma
selumetinib
Sensitive
:
C2
GNAQ mutation
Uveal Melanoma
trametinib
Sensitive
:
C2
MBD4 mutation
Uveal Melanoma
nivolumab
Sensitive
:
C3
CXCL10 elevation
Uveal Melanoma
IMCgp100
Sensitive
:
C3
GNAQ mutation
Uveal Melanoma
pembrolizumab
Sensitive
:
C3
GNA11 mutation
Uveal Melanoma
pembrolizumab
Sensitive
:
C3
GNA11 Q209L
Uveal Melanoma
IDE196
Sensitive
:
C3
LDH-H
Uveal Melanoma
nivolumab
Sensitive
:
C3
LDH-H
Uveal Melanoma
pembrolizumab
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our